Matinas BioPharma Holdings, Inc. — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Matinas BioPharma filed an 8-K on 2026-09-16 disclosing Item 8.01 (Other Events). The filing documents do not contain the actual text of the event disclosure—only the structural EDGAR metadata and XBRL file references are visible in this excerpt. No specific counterparties, dollar amounts, dates, or business developments are stated in the provided material.
Why this rating
Filing is procedural disclosure with no substantive event details disclosed in excerpt. Insufficient information to assess any business impact.
Extracted items
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.